Related Experiment Video
Updated: May 17, 2026

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound
Published on: December 2, 2014
Hemoglobin A1c and arterial and ventricular stiffness in older adults
Susan J Zieman1, Aruna Kamineni, Joachim H Ix
1National Institute on Aging, National Institutes of Health, Bethesda, Maryland, United States of America.
Insights
In older adults without diabetes, hemoglobin A1c (HbA1c) did not correlate with arterial or ventricular stiffness. Fasting glucose, however, showed significant associations with these stiffness measures.
Area of Science:
- Cardiovascular Health
- Gerontology
- Metabolic Diseases
Background:
- Arterial and ventricular stiffening are linked to diabetes and aging, increasing morbidity and mortality.
- Advanced glycation endproducts (AGE) are implicated in the pathophysiology of stiffening.
- Glycated hemoglobin (HbA1c) is an AGE marker, but its role in stiffness in non-diabetic individuals is unclear.
Purpose of the Study:
- To investigate the association between HbA1c and measures of arterial and ventricular stiffness.
- To compare these associations with those of fasting glucose (FG) in older adults without diabetes.
Main Methods:
- Cross-sectional analysis of 830 participants (aged ≥ 65) from the Cardiovascular Health Study without diabetes.
- Measurements included HbA1c, FG, echocardiography, blood pressure, and carotid ultrasonography.
- Adjusted linear regression models were used to assess associations.
Main Results:
- HbA1c showed no association with arterial stiffness (e.g., pulse pressure, carotid intima-media thickness) or ventricular stiffness (e.g., left ventricular mass).
- Fasting glucose levels were positively associated with systolic and diastolic blood pressure, pulse pressure, and left ventricular mass.
- HbA1c correlated with FG, BMI, and Black race.
Conclusions:
- In older adults without diabetes, HbA1c is not associated with arterial or ventricular stiffness.
- Fasting glucose is associated with increased arterial and ventricular stiffness in this population.
- Alternative AGE markers may be more relevant for assessing AGEs' role in vascular stiffening in older adults.
Objective:
Arterial and ventricular stiffening are characteristics of diabetes and aging which confer significant morbidity and mortality; advanced glycation endproducts (AGE) are implicated in this stiffening pathophysiology. We examined the association between HbA(1c), an AGE, with arterial and ventricular stiffness measures in older individuals without diabetes.
Research Design & Methods:
Baseline HbA(1c) was measured in 830 participants free of diabetes defined by fasting glucose or medication use in the Cardiovascular Health Study, a population-based cohort study of adults aged ≥ 65 years. We performed cross-sectional analyses using baseline exam data including echocardiography, ankle and brachial blood pressure measurement, and carotid ultrasonography. We examined the adjusted associations between HbA(1c) and multiple arterial and ventricular stiffness measures by linear regression models and compared these results to the association of fasting glucose (FG) with like measures.
Results:
HbA(1c) was correlated with fasting and 2-hour postload glucose levels (r = 0.21; p<0.001 for both) and positively associated with greater body-mass index and black race. In adjusted models, HbA(1c) was not associated with any measure of arterial or ventricular stiffness, including pulse pressure (PP), carotid intima-media thickness, ankle-brachial index, end-arterial elastance, or left ventricular mass (LVM). FG levels were positively associated with systolic, diastolic and PP and LVM.
Conclusions:
In this sample of older adults without diabetes, HbA(1c) was not associated with arterial or ventricular stiffness measures, whereas FG levels were. The role of AGE in arterial and ventricular stiffness in older adults may be better assessed using alternate AGE markers.
Related Concept Videos
Assessing Blood pressure in the Leg
Preparation:
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Pharmacodynamics in Geriatric Patients: Effects of Age
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Hypertension III: Clinical Manifestations and Diagnostic Studies
Assessment of blood pressure in brachial artery(two-step method)

